Ryvu Therapeutics Statistics

Total Valuation

WSE:RVU has a market cap or net worth of PLN 691.29 million. The enterprise value is 649.92 million.

Market Cap	691.29M
Enterprise Value	649.92M

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:RVU has 23.12 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	19.07M
Shares Outstanding	23.12M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-17.09%
Owned by Insiders (%)	23.59%
Owned by Institutions (%)	42.68%
Float	17.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.65
PB Ratio	9.71
P/TBV Ratio	10.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.48
EV / Sales	7.19
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.59

Financial Position

The company has a current ratio of 2.27, with a Debt / Equity ratio of 1.34.

Current Ratio	2.27
Quick Ratio	2.16
Debt / Equity	1.34
Debt / EBITDA	n/a
Debt / FCF	-0.82
Interest Coverage	-14.53

Financial Efficiency

Return on equity (ROE) is -95.35% and return on invested capital (ROIC) is -35.81%.

Return on Equity (ROE)	-95.35%
Return on Assets (ROA)	-23.12%
Return on Invested Capital (ROIC)	-35.81%
Return on Capital Employed (ROCE)	-66.30%
Revenue Per Employee	275,640
Profits Per Employee	-361,866
Employee Count	328
Asset Turnover	0.27
Inventory Turnover	10.02

Taxes

In the past 12 months, WSE:RVU has paid 173,000 in taxes.

Income Tax	173,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.37% in the last 52 weeks. The beta is 0.54, so WSE:RVU's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-41.37%
50-Day Moving Average	26.08
200-Day Moving Average	27.95
Relative Strength Index (RSI)	69.74
Average Volume (20 Days)	58,013

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:RVU had revenue of PLN 90.41 million and -118.69 million in losses. Loss per share was -5.14.

Revenue	90.41M
Gross Profit	73.83M
Operating Income	-121.78M
Pretax Income	-118.52M
Net Income	-118.69M
EBITDA	-111.96M
EBIT	-121.78M
Loss Per Share	-5.14

Full Income Statement

Balance Sheet

The company has 136.56 million in cash and 95.19 million in debt, giving a net cash position of 41.37 million or 1.79 per share.

Cash & Cash Equivalents	136.56M
Total Debt	95.19M
Net Cash	41.37M
Net Cash Per Share	1.79
Equity (Book Value)	71.22M
Book Value Per Share	3.08
Working Capital	90.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -113.94 million and capital expenditures -2.42 million, giving a free cash flow of -116.36 million.

Operating Cash Flow	-113.94M
Capital Expenditures	-2.42M
Free Cash Flow	-116.36M
FCF Per Share	-5.03

Full Cash Flow Statement

Margins

Gross margin is 81.66%, with operating and profit margins of -134.69% and -131.28%.

Gross Margin	81.66%
Operating Margin	-134.69%
Pretax Margin	-131.09%
Profit Margin	-131.28%
EBITDA Margin	-123.83%
EBIT Margin	-134.69%
FCF Margin	n/a

Dividends & Yields

WSE:RVU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.00%
Earnings Yield	-17.17%
FCF Yield	-16.83%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:RVU has an Altman Z-Score of 0.64 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.64
Piotroski F-Score	4